Analysis
PublicGENENTECH USA, INC holds $136.1M across 34 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award under parent 36F79723D0219. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Jan 29, 2027 PoP end — agencies typically plan 12–18 months ahead.
Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES
Recompete timing
PublicCurrent PoP ends Jan 29, 2027 (166 days remaining). Agencies typically plan 12–18 months ahead — at 5.5 months out, that window is already open. The buying decision is likely already in motion.
Watch this contract — one email →Incumbent footprint
Public recordGENENTECH USA, INC — $136.1M obligated across 34 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open GENENTECH USA, INC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract 75A50325F80003?
75A50325F80003 (OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES) is a Department of Health and Human Services (HHS) award with an estimated value of $45.1M, currently held by GENENTECH USA, INC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on 75A50325F80003?
GENENTECH USA, INC is the incumbent with $136.1M across 34 related awards in SCOUT’s public footprint. The current period of performance ends Jan 29, 2027.
When does 75A50325F80003 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →